Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Sea Ltd: Another Sell-Off? and more

In today’s briefing:

  • Sea Ltd: Another Sell-Off?
  • Buy Country Garden Services on China Property Sector Recovery
  • Tokyo Electron (8035 JP): Sell into the Bear Market Bounce
  • Suzuken Buyback (9987 JP) – The Best News In Years
  • Palantir Inc: Major Drivers
  • Dongfang Electric (1072 HK) And CIMC Enric (3669 HK): Two Stocks for the Next Five Years
  • Apollo Hospitals Enterprise (APHS IN): Mixed 2QFY23 Result; Outlook Is Positive
  • Block Inc (formerly Square Inc): Continuing Bullish Approach Towards Crypto
  • Datadog Inc: The Cloudcraft Acquisition & Other Drivers
  • Thermax (TMX IN): Strong Order Book Entails Visibility Amid Margin Pressure

Sea Ltd: Another Sell-Off?

By Oshadhi Kumarasiri

  • The last leg of Sea Ltd (SE US)’s original bull thesis is about to break with Shopee’s revenue expected to start declining from 3Q22 onwards.
  • However, a lower-than-expected operating loss, driven by cost-cutting could get the bulls excited for a short while following the 3Q22 results due later this week.
  • With the business remaining unprofitable after cost-cutting, we think 3Q22 results could be another opportunity to profit on the short-side as the FV of Sea could be around $10bn EV.

Buy Country Garden Services on China Property Sector Recovery

By Xin Yu, CFA

  • Chinese government outlined 16 steps to support the property industry on Nov 11
  • The newly released measures clearly show that the government has reversed its attitude toward property industry, which may trigger the end of the downcycle.
  • During the property sector rebound, Country Garden Services (CGS) can be a good investment. The company has a solid track record and shows attractive valuation.

Tokyo Electron (8035 JP): Sell into the Bear Market Bounce

By Scott Foster

  • Tokyo Electron (TEL) has cut sales guidance for 2H of FY Mar-23 by more than 25% and operating profit guidance by more than 50%. 
  • Half of the reduction in sales guidance is due U.S. sanctions on China. Management does not expect demand to pick up until the second half of next year. 
  • The share price has risen by more than 30% in the past five weeks after a slight decline in U.S. inflation. Projected valuations are not particularly attractive.

Suzuken Buyback (9987 JP) – The Best News In Years

By Travis Lundy

  • Suzuken Co Ltd (9987 JP) last Friday announced earnings which beat expectations and raised forecasts well above consensus. But Implied H2 did not change, suggesting full-year is lowballed.
  • The company announced a buyback over 5 months, but today (Tuesday) announced a ToSTNeT-3 buyback for the full size (6% or so) that morning. 
  • It looks like insider selling, which in addition to being accretive would be bullish on a governance basis.

Palantir Inc: Major Drivers

By Baptista Research

  • Palantir delivered a mixed set of results in the last quarter.
  • Its $478 million in revenue surpassed Wall Street expectations but the company missed out on the earnings expectations of analysts.
  • U.S. commercial business expanded for the ninth consecutive quarter, up 53% yearly.

Dongfang Electric (1072 HK) And CIMC Enric (3669 HK): Two Stocks for the Next Five Years

By Osbert Tang, CFA

  • China’s ambition to build into a strong manufacturing country as revealed in 20th Party Congress should place Dongfang Electric (1072 HK) and CIMC Enric Holdings (3899 HK) in excellent positions.
  • The leadership in power and new energy equipment industry, improving gross margin outlook, well-covered order book and undemanding multiples are the key merits of Dongfang Electric (1072 HK)
  • CIMC Enric Holdings (3899 HK)‘s good presence in clean energy, chemical/environmental and liquid food segments, global product competitiveness, secured order backlog and net cash position are its major edges. 

Apollo Hospitals Enterprise (APHS IN): Mixed 2QFY23 Result; Outlook Is Positive

By Tina Banerjee

  • Apollo Hospitals Enterprise (APHS IN) recorded 14% y/y growth in revenue in Q2FY23. Occupancy in both the mature as well as new hospitals improved in Q2FY23 compared to prior quarter.
  • Q2FY23 reported EBITDA declined 8% y/y to INR5.65 billion due to impact of 24/7 operating costs, which stood at INR1.74 billion (vs INR475 million in Q2FY22).
  • In October, Apollo Hospitals entered into a definitive agreement to acquire 60% stake in Kerala First Health Services Limited, which offers Ayurveda medical services under the “AyurVAID Hospitals” brand.

Block Inc (formerly Square Inc): Continuing Bullish Approach Towards Crypto

By Baptista Research

  • Block delivered a decent set of results with an all-around beat and good profitability during the last quarter.
  • Its BNPL platform produced $150 million in gross profit in the third quarter, distributed between Square and Cash App.
  • Inflows per active user have been improving in the third quarter compared to the first and second quarters and stable year over year.

Datadog Inc: The Cloudcraft Acquisition & Other Drivers

By Baptista Research

  • Like most technology stocks, Datadog has also taken a massive beating in terms of its share price but its financial performance has been good.
  • The company reported strong results for the third quarter and managed an all-around beat.
  • Since customers continue to manage their companies with greater cost consciousness, the company observed current customer usage growth at similar levels as Q2.

Thermax (TMX IN): Strong Order Book Entails Visibility Amid Margin Pressure

By Tina Banerjee

  • In Q2FY23, Thermax (TMX IN) recorded strong revenue growth of 41% y/y to Rs20.8bn, driven by strong growth across all the three segments.
  • The company bore the brunt of high raw material prices as EBIT margins saw a 900 bps decline y/y to 6.9%. However, EBIT margin improved 200 bps over Q1FY23.
  • The order book of the company grew 46% y/y to Rs94.8bn. Order book is well diversified across sectors. Domestic orders comprised ~84% of the order book.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars